298 related articles for article (PubMed ID: 34808393)
1. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.
Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ
Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
Hu MJ; Long M; Dai RJ
Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
Chen X; Tan XR; Li SJ; Zhang XX
Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.
Sun Y; Song Y; Liu C; Geng J
Biochem Biophys Res Commun; 2019 Aug; 516(2):584-590. PubMed ID: 31239155
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
7. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.
Jin SS; Lin XF; Zheng JZ; Wang Q; Guan HQ
Eur Cytokine Netw; 2019 Sep; 30(3):98-106. PubMed ID: 31957704
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
9. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.
Wan Y; Yang ZQ
Cell Cycle; 2020 Feb; 19(4):419-431. PubMed ID: 31948324
[TBL] [Abstract][Full Text] [Related]
10. ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.
Dong Y; Hu M; Tan K; Dai R
Epigenetics; 2023 Dec; 18(1):2239592. PubMed ID: 37566742
[TBL] [Abstract][Full Text] [Related]
11. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.
Wang X
J Cell Biochem; 2018 Feb; 119(2):1567-1574. PubMed ID: 28771824
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of NEAT1 prevented MPP
Zhou S; Zhang D; Guo J; Chen Z; Chen Y; Zhang J
Brain Res; 2021 Jan; 1750():147156. PubMed ID: 33069733
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L
Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144
[TBL] [Abstract][Full Text] [Related]
15. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice.
Ma M; Duan R; Shen L; Liu M; Ji Y; Zhou H; Li C; Liang T; Li X; Guo L
J Lipid Res; 2020 Jul; 61(7):1052-1064. PubMed ID: 32229588
[TBL] [Abstract][Full Text] [Related]
18. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.
Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Sun M; Pang C; Qu J; Liu G; Li J
Oncotarget; 2016 Jun; 7(24):36207-36219. PubMed ID: 27166182
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA NEAT1 knockdown inhibits MPP
Liu R; Li F; Zhao W
Neurosci Lett; 2020 Jul; 731():135060. PubMed ID: 32442477
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 activates MyD88/NF-κB pathway in bronchopneumonia through targeting miR-155-5p.
Chen LJ; Li JM; Zhang WD; Liu W; Li XY; Ouyang B; Tan JL; Li Y; Chen JC; Liu ZG
Autoimmunity; 2021 Mar; 54(2):104-113. PubMed ID: 33719773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
